{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:25:38Z","timestamp":1793931938060,"version":"4.8.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1195460"],"award-info":[{"award-number":["1195460"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jclinepi.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jclinepi.2026.112502","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:07:03Z","timestamp":1789024023000},"page":"112502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Barriers and enablers to integrating deprescribing recommendations into clinical practice guidelines: a qualitative study"],"prefix":"10.1016","volume":"200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7308-0572","authenticated-orcid":false,"given":"Shin J.","family":"Liau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4151-8864","authenticated-orcid":false,"given":"Deanna","family":"Mill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling M.","family":"McEvoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3206-4867","authenticated-orcid":false,"given":"Selina","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6604-0609","authenticated-orcid":false,"given":"Danielle","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wade","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Moriarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagham J.","family":"Ailabouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danijela","family":"Gnjidic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1405-999X","authenticated-orcid":false,"given":"Emily","family":"Reeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jclinepi.2026.112502_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161248","article-title":"Methodology for developing deprescribing guidelines: using evidence and GRADE to guide recommendations for deprescribing","volume":"11","author":"Farrell","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jclinepi.2026.112502_bib2","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/bcp.12732","article-title":"A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practice","volume":"80","author":"Reeve","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.jclinepi.2026.112502_bib3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/joim.13599","article-title":"Implementation considerations of deprescribing interventions: a scoping review","volume":"295","author":"Wang","year":"2024","journal-title":"J Intern Med"},{"issue":"4","key":"10.1016\/j.jclinepi.2026.112502_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ppar\/pry030","article-title":"Provider and system-level barriers to deprescribing: interconnected problems and solutions","volume":"28","author":"Linsky","year":"2018","journal-title":"Public Policy Aging Rep"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112502_bib5","first-page":"28","article-title":"What do clinical practice guidelines say about deprescribing? A scoping review","volume":"34","author":"Langford","year":"2024","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.jclinepi.2026.112502_bib6","series-title":"Clinical practice guidelines we can trust","article-title":"Committee on standards for developing trustworthy clinical practice guidelines","year":"2011"},{"issue":"5","key":"10.1016\/j.jclinepi.2026.112502_bib7","first-page":"354","article-title":"Deprescribing proton pump inhibitors: evidence-based clinical practice guideline","volume":"63","author":"Farrell","year":"2017","journal-title":"Can Fam Physician"},{"issue":"11","key":"10.1016\/j.jclinepi.2026.112502_bib8","first-page":"832","article-title":"Deprescribing antihyperglycemic agents in older persons: evidence-based clinical practice guideline","volume":"63","author":"Farrell","year":"2017","journal-title":"Can Fam Physician"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112502_bib9","first-page":"17","article-title":"Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: evidence-based clinical practice guideline","volume":"64","author":"Bjerre","year":"2018","journal-title":"Can Fam Physician"},{"issue":"5","key":"10.1016\/j.jclinepi.2026.112502_bib10","first-page":"339","article-title":"Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline","volume":"64","author":"Pottie","year":"2018","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jclinepi.2026.112502_bib11","series-title":"Evidence-based clinical practice guideline for deprescribing cholinesterase inhibitors and memantine in people with dementia","author":"Reeve","year":"2018"},{"key":"10.1016\/j.jclinepi.2026.112502_bib12","series-title":"Evidence-based clinical practice guideline for deprescribing opioid analgesics","author":"Langford","year":"2022"},{"issue":"6","key":"10.1016\/j.jclinepi.2026.112502_bib13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"issue":"2","key":"10.1016\/j.jclinepi.2026.112502_bib14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112502_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1748-5908-7-37","article-title":"Validation of the theoretical domains framework for use in behaviour change and implementation research","volume":"7","author":"Cane","year":"2012","journal-title":"Implement Sci"},{"issue":"6","key":"10.1016\/j.jclinepi.2026.112502_bib16","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.sapharm.2018.08.014","article-title":"Deprescribing recommendations: an essential consideration for clinical guideline developers","volume":"15","author":"Moriarty","year":"2019","journal-title":"Res Social Adm Pharm"},{"issue":"13","key":"10.1016\/j.jclinepi.2026.112502_bib17","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1177\/1049732315617444","article-title":"Sample size in qualitative interview studies: guided by information power","volume":"26","author":"Malterud","year":"2016","journal-title":"Qual Health Res"},{"key":"10.1016\/j.jclinepi.2026.112502_bib18","series-title":"Qualitative research in psychology: expanding perspectives in methodology and design","first-page":"67","article-title":"Information power: sample content and size in qualitative studies","author":"Malterud","year":"2021"},{"key":"10.1016\/j.jclinepi.2026.112502_bib19","doi-asserted-by":"crossref","DOI":"10.1177\/16094069241296206","article-title":"Sample sizes for 10 types of qualitative data analysis: an integrative review, empirical guidance, and next steps","volume":"23","author":"Wutich","year":"2024","journal-title":"Int J Qual Methods"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112502_bib21","first-page":"111","article-title":"Inductive content analysis: a guide for beginning qualitative researchers","volume":"23","author":"Vears","year":"2022","journal-title":"Focus Health Prof Educ"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112502_bib22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jac5.1743","article-title":"Overview of clinical practice guideline development, application to pharmacy practice, and roles for pharmacists","volume":"6","author":"Dixon","year":"2022","journal-title":"J Am Coll Clin Pharm"},{"issue":"2","key":"10.1016\/j.jclinepi.2026.112502_bib23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/jac5.1056","article-title":"Pharmacist authorship on clinical practice guidelines","volume":"2","author":"Thompkins","year":"2018","journal-title":"J Am Coll Clin Pharm"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112502_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jac5.1015","article-title":"Systematic evaluation of the methodological quality of clinical practice guidelines intended for pharmacists","volume":"2","author":"Beckett","year":"2018","journal-title":"J Am Coll Clin Pharm"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112502_bib25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s43058-022-00315-0","article-title":"The effectiveness of champions in implementing innovations in health care: a systematic review","volume":"3","author":"Santos","year":"2022","journal-title":"Implement Sci Commun"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112502_bib26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s43058-021-00185-y","article-title":"Champions for improved adherence to guidelines in long-term care homes: a systematic review","volume":"2","author":"Hall","year":"2021","journal-title":"Implement Sci Commun"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112502_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13012-020-01048-1","article-title":"Lessons learned about the effective operationalization of champions as an implementation strategy: results from a qualitative process evaluation of a pragmatic trial","volume":"15","author":"Bunce","year":"2020","journal-title":"Implement Sci"},{"key":"10.1016\/j.jclinepi.2026.112502_bib28","series-title":"Improving healthcare quality in Europe","first-page":"233","article-title":"Clinical practice guidelines as a quality strategy","author":"Panteli","year":"2019"},{"issue":"9","key":"10.1016\/j.jclinepi.2026.112502_bib29","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jama.2015.7462","article-title":"Specialty society clinical practice guidelines: time for evolution or revolution?","volume":"314","author":"Classen","year":"2015","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jclinepi.2026.112502_bib30","doi-asserted-by":"crossref","first-page":"490","DOI":"10.5694\/j.1326-5377.2010.tb03604.x","article-title":"Australian clinical practice guidelines--a national study","volume":"192","author":"Buchan","year":"2010","journal-title":"Med J Aust"},{"issue":"3","key":"10.1016\/j.jclinepi.2026.112502_bib31","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/jch.14226","article-title":"Comparison of guidelines for the management of hypertension: similarities and differences between international and Asian countries; perspectives from HOPE-Asia network","volume":"23","author":"Chia","year":"2021","journal-title":"J Clin Hypertens"},{"issue":"2","key":"10.1016\/j.jclinepi.2026.112502_bib32","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/jgs.16219","article-title":"Recommendations for (discontinuation of) statin treatment in older adults: review of guidelines","volume":"68","author":"van der Ploeg","year":"2020","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112502_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/0706743716664885","article-title":"Systematic review of clinical practice guidelines for failed antidepressant treatment response in major depressive disorder, dysthymia, and subthreshold depression in adults","volume":"62","author":"MacQueen","year":"2017","journal-title":"Can J Psychiatry"},{"issue":"5","key":"10.1016\/j.jclinepi.2026.112502_bib34","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-0092","article-title":"International variation in asthma and bronchiolitis guidelines","volume":"140","author":"Bakel","year":"2017","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.jclinepi.2026.112502_bib35","doi-asserted-by":"crossref","first-page":"548","DOI":"10.7326\/M14-1885","article-title":"Guidelines International Network: principles for disclosure of interests and management of conflicts in guidelines","volume":"163","author":"Sch\u00fcnemann","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jclinepi.2026.112502_bib37","unstructured":"National Health and Medical Research Council. Guidelines for Guidelines Handbook Available at: https:\/\/www.nhmrc.gov.au\/guidelinesforguidelines. [Accessed 12 May 2025]."},{"issue":"7","key":"10.1016\/j.jclinepi.2026.112502_bib38","doi-asserted-by":"crossref","first-page":"499","DOI":"10.46747\/cfp.6707499","article-title":"Endorsement of clinical practice guidelines: criteria from the College of Family Physicians of Canada","volume":"67","author":"Allan","year":"2021","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jclinepi.2026.112502_bib39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jclinepi.2021.01.001","article-title":"Challenges in applying the GRADE approach in public health guidelines and systematic reviews: a concept article from the GRADE Public Health Group","volume":"135","author":"Hilton","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2026.112502_bib40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jclinepi.2020.10.017","article-title":"Guidelines rarely used GRADE and applied methods inconsistently: a methodological study of Australian guidelines","volume":"130","author":"Barker","year":"2021","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.jclinepi.2026.112502_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250356","article-title":"Over half of clinical practice guidelines use non-systematic methods to inform recommendations: a methods study","volume":"16","author":"Lunny","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jclinepi.2026.112502_bib42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jclinepi.2020.01.026","article-title":"Guideline developers in the United States were inconsistent in applying criteria for appropriate grading of recommendations, assessment, development and evaluation use","volume":"124","author":"Dixon","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2026.112502_bib43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jclinepi.2021.08.013","article-title":"Clinical epidemiology in China series. Paper 4: the reporting and methodological quality of Chinese clinical practice guidelines published between 2014 and 2018: a systematic review","volume":"140","author":"Zhou","year":"2021","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112502_bib44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12992-019-0455-0","article-title":"Review of evidence based clinical practice guidelines developed in Latin America and Caribbean during the last decade: an analysis of the methods for grading quality of evidence and topic prioritization","volume":"15","author":"Cabrera","year":"2019","journal-title":"Glob Health"},{"issue":"2","key":"10.1016\/j.jclinepi.2026.112502_bib45","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/jep.13447","article-title":"Methodological assessment of Mexican clinical practice guidelines: GRADE framework adherence and critical appraisal","volume":"27","author":"Colunga-Lozano","year":"2021","journal-title":"J Eval Clin Pract"},{"issue":"1 Suppl","key":"10.1016\/j.jclinepi.2026.112502_bib46","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1177\/0194599812468849","article-title":"Clinical practice guideline development manual, third edition: a quality-driven approach for translating evidence into action","volume":"148","author":"Rosenfeld","year":"2013","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112502_bib47","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1748-5908-7-60","article-title":"Developing clinical practice guidelines: target audiences, identifying topics for guidelines, guideline group composition and functioning and conflicts of interest","volume":"7","author":"Eccles","year":"2012","journal-title":"Implement Sci"},{"key":"10.1016\/j.jclinepi.2026.112502_bib48","series-title":"Deprescribing in clinical practice: evidence, implementation, and the role of pharmacists. Reference Module in Biomedical Sciences","author":"Liau","year":"2026"},{"key":"10.1016\/j.jclinepi.2026.112502_bib49","series-title":"Setting priorities for clinical practice guidelines","article-title":"Committee on methods for setting priorities for guideline development","year":"1995"},{"issue":"3","key":"10.1016\/j.jclinepi.2026.112502_bib51","doi-asserted-by":"crossref","first-page":"E123","DOI":"10.1503\/cmaj.131237","article-title":"Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise","volume":"186","author":"Schunemann","year":"2014","journal-title":"CMAJ Feb 18"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112502_bib53","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1186\/s12913-019-4567-2","article-title":"Prioritization approaches in the development of health practice guidelines: a systematic review","volume":"19","author":"El-Harakeh","year":"2019","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"10.1016\/j.jclinepi.2026.112502_bib54","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1513\/pats.201208-055ST","article-title":"Priority setting in guideline development: article 2 in integrating and coordinating efforts in COPD guideline development. An official ATS\/ERS workshop report","volume":"9","author":"Atkins","year":"2012","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.jclinepi.2026.112502_bib55","series-title":"Polypharmacy and geriatrics","first-page":"93","article-title":"Development and implementation of deprescribing guidelines","author":"Langford","year":"2025"},{"issue":"5","key":"10.1016\/j.jclinepi.2026.112502_bib56","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afab282","article-title":"Clinical trials in older people","volume":"51","author":"Pitkala","year":"2022","journal-title":"Age Ageing"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112502_bib57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jamda.2020.05.004","article-title":"Medication management in frail older people: consensus principles for clinical practice, research, and education","volume":"22","author":"Liau","year":"2021","journal-title":"J Am Med Dir Assoc"},{"issue":"10","key":"10.1016\/j.jclinepi.2026.112502_bib58","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4140\/TCP.n.2021.469","article-title":"Frailty status and cognitive function should guide prescribing in long-term care facilities","volume":"36","author":"Liau","year":"2021","journal-title":"Sr Care Pharm"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112502_bib59","first-page":"4","article-title":"The limitations of using randomised controlled trials as a basis for developing treatment guidelines. Evid Based Ment","volume":"21","author":"Mulder","year":"2018","journal-title":"Health"},{"issue":"5","key":"10.1016\/j.jclinepi.2026.112502_bib60","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/0306312713483679","article-title":"Being \u2018evidence-based\u2019 in the absence of evidence: the management of non-evidence in guideline development","volume":"43","author":"Knaapen","year":"2013","journal-title":"Social Stud Sci"},{"issue":"4","key":"10.1016\/j.jclinepi.2026.112502_bib61","doi-asserted-by":"crossref","first-page":"358","DOI":"10.7861\/clinmedicine.10-4-358","article-title":"A review of grading systems for evidence-based guidelines produced by medical specialties","volume":"10","author":"Baker","year":"2010","journal-title":"Clin Med (Lond)"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112502_bib62","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/imj.14466","article-title":"Evidence-poor medicine: just how evidence-based are Australian clinical practice guidelines?","volume":"50","author":"Venus","year":"2020","journal-title":"Intern Med J"},{"issue":"10","key":"10.1016\/j.jclinepi.2026.112502_bib63","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/apt.12290","article-title":"Systematic review: the quality of the scientific evidence and conflicts of interest in international inflammatory bowel disease practice guidelines","volume":"37","author":"Feuerstein","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112502_bib64","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.mayocp.2013.09.013","article-title":"Systematic analysis underlying the quality of the scientific evidence and conflicts of interest in interventional medicine subspecialty guidelines","volume":"89","author":"Feuerstein","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jclinepi.2026.112502_bib65","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.wneu.2016.02.044","article-title":"Appraisal of the quality of neurosurgery clinical practice guidelines","volume":"90","author":"Ducis","year":"2016","journal-title":"World Neurosurg"},{"issue":"2","key":"10.1016\/j.jclinepi.2026.112502_bib66","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.1503\/cmaj.190144","article-title":"Guideline groups should make recommendations even if the evidence is considered insufficient","volume":"192","author":"Neumann","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/j.jclinepi.2026.112502_bib67","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jclinepi.2021.02.026","article-title":"GRADE notes: how to use GRADE when there is \u201cno\u201d evidence? A case study of the expert evidence approach","volume":"137","author":"Mustafa","year":"2021","journal-title":"J Clin Epidemiol"},{"issue":"10151","key":"10.1016\/j.jclinepi.2026.112502_bib68","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0140-6736(18)31671-4","article-title":"When no guideline recommendation is the best recommendation","volume":"392","author":"Bretthauer","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jclinepi.2026.112502_bib69","doi-asserted-by":"crossref","DOI":"10.1007\/s11606-026-10679-x","article-title":"Designing implementable deprescribing recommendations: a qualitative study of healthcare professional perspectives","author":"Langford","year":"2026","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jclinepi.2026.112502_bib70","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jclinepi.2018.01.012","article-title":"GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence","volume":"111","author":"Schunemann","year":"2019","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2026.112502_bib71","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jclinepi.2021.11.026","article-title":"GRADE guidance 24 optimizing the integration of randomized and non-randomized studies of interventions in evidence syntheses and health guidelines","volume":"142","author":"Cuello-Garcia","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2026.112502_bib72","author":"Thompson"},{"key":"10.1016\/j.jclinepi.2026.112502_bib73","doi-asserted-by":"crossref","first-page":"111204","DOI":"10.1016\/j.jclinepi.2023.10.020","article-title":"Context matters: using an Evidence to Decision (EtD) framework to develop and encourage uptake of opioid deprescribing guideline recommendations at the point-of-care","volume":"165","author":"Langford","year":"2024","journal-title":"J Clin Epidemiol"},{"issue":"15","key":"10.1016\/j.jclinepi.2026.112502_bib75","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain--United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jclinepi.2026.112502_bib76","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jama.2021.11013","article-title":"Association of dose tapering with overdose or mental health crisis among patients prescribed long-term opioids","volume":"326","author":"Agnoli","year":"2021","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jclinepi.2026.112502_bib77","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/pm\/pny307","article-title":"Challenges with implementing the Centers for Disease Control and Prevention opioid guideline: a consensus panel report","volume":"20","author":"Kroenke","year":"2019","journal-title":"Pain Med"},{"issue":"6","key":"10.1016\/j.jclinepi.2026.112502_bib78","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.16726","article-title":"Long-term risk of overdose or mental health crisis after opioid dose tapering","volume":"5","author":"Fenton","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.jclinepi.2026.112502_bib79","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jclinepi.2014.12.013","article-title":"Guideline uptake is influenced by six implementability domains for creating and communicating guidelines: a realist review","volume":"68","author":"Kastner","year":"2015","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.jclinepi.2026.112502_bib80","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/j.sapharm.2021.04.004","article-title":"Deprescribing: moving beyond barriers and facilitators","volume":"18","author":"Thompson","year":"2022","journal-title":"Res Social Adm Pharm"},{"issue":"10","key":"10.1016\/j.jclinepi.2026.112502_bib81","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s40266-013-0106-8","article-title":"Patient barriers to and enablers of deprescribing: a systematic review","volume":"30","author":"Reeve","year":"2013","journal-title":"Drugs Aging"},{"issue":"12","key":"10.1016\/j.jclinepi.2026.112502_bib82","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006544","article-title":"Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis","volume":"4","author":"Anderson","year":"2014","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.jclinepi.2026.112502_bib83","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/ijpp\/riad001","article-title":"Barriers and facilitators of implementing proactive deprescribing within primary care: a systematic review","volume":"31","author":"Okeowo","year":"2023","journal-title":"Int J Pharm Pract"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112502_bib84","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afab250","article-title":"Barriers and enablers to deprescribing in long-term care facilities: a 'best-fit' framework synthesis of the qualitative evidence","volume":"51","author":"Heinrich","year":"2022","journal-title":"Age Ageing"},{"issue":"3","key":"10.1016\/j.jclinepi.2026.112502_bib85","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.sapharm.2021.05.018","article-title":"Leveraging implementation science to increase the translation of deprescribing evidence into practice","volume":"18","author":"Ailabouni","year":"2022","journal-title":"Res Social Adm Pharm"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112502_bib86","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13012-017-0668-7","article-title":"Number and type of guideline implementation tools varies by guideline, clinical condition, country of origin, and type of developer organization: content analysis of guidelines","volume":"12","author":"Liang","year":"2017","journal-title":"Implement Sci"},{"issue":"10","key":"10.1016\/j.jclinepi.2026.112502_bib87","doi-asserted-by":"crossref","first-page":"666","DOI":"10.46747\/cfp.6910666","article-title":"Ten years of deprescribing guideline work: where are we now?","volume":"69","author":"Farrell","year":"2023","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jclinepi.2026.112502_bib89","author":"Agoritsas"},{"issue":"12","key":"10.1016\/j.jclinepi.2026.112502_bib90","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1007\/s11606-025-09499-2","article-title":"Joint clinical practice guideline on benzodiazepine tapering: considerations when risks outweigh benefits","volume":"40","author":"Brunner","year":"2025","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jclinepi.2026.112502_bib91","doi-asserted-by":"crossref","DOI":"10.7326\/ANNALS-25-00431","article-title":"GRADE guidance: update on developing Good Practice Statements in guidelines","author":"Dewidar","year":"2026","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.jclinepi.2026.112502_bib92","article-title":"Older adults\u2019 attitudes toward deprescribing in 14 countries","volume":"8","author":"Vidonscky","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112502_bib93","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/s12875-025-03042-2","article-title":"Attitudes and confidence toward deprescribing: a survey among Italian general practitioners","volume":"26","author":"Rossi","year":"2025","journal-title":"BMC Prim Care"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435626003781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435626003781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:32:44Z","timestamp":1793928764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435626003781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":87,"alternative-id":["S0895435626003781"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2026.112502","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Barriers and enablers to integrating deprescribing recommendations into clinical practice guidelines: a qualitative study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinepi.2026.112502","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112502"}}